EIN/Pressire rejects our Cardio-C press release on the basis of "content"

[ofonorow]

Their email:

EIN Presswire

10:54 AM (6 hours ago)

to support
Hello Owen,

This email is related to your recently submitted press release titled:
Vitamin C Foundation Announces New Pauling-therapy Maintenance Formula

This is to inform you that we have declined your press release due to its content not conforming to our guidelines.

Please refer to our Editorial Guidelines:
https://www.einpresswire.com/editorial-guidelines

If you have any questions, please reply to this email or use the contact form at https://www.einpresswire.com/contact.

Best regards,

Editorial Department
EIN Presswire
Washington, DC

EIN Presswire - Everyone's Internet News Presswire™
https://www.einpresswire.com


A copy of the press release that violates their guidelines for content

Vitamin C Foundation Announces New Pauling-therapy Maintenance Formula
News Provided By
Vitamin C Foundation
Not published yet


Cardio-C XM Pauling Therapy Formula

The Cardio-C™ XM powdered drink mix provides an economical way to follow Linus Pauling's recommendations over the long term - without pills!

American scientist invents a method for reversing heart disease that could prevent 350,000 heart bypass operations every year.”
— Owen Fonorow

NAPERVILLE, ILLINOIS, USA, June 29, 2024 /EINPresswire.com/ -- The Vitamin C Foundation has been offering Cardio-C™drink mixes for almost 30 years. The new Cardio-C™ XM long-term maintenance formula retains vitamin C and lysine, adds magnesium (as magnesium ascorbate) and switches stevia to the under appreciated vital healing nutrient glucose (as dextrose) per the recommendations of Anthony William, the Medical Medium.

The new maintenance product is a good source of vitamin C (and lysine). It is not as sweet as our other Cardio-C™ products and can be added to otherwise low-sugar fruit smoothies. As with all our Cardio-C™ drink mix formulas, the economical Cardio-C™ XM avoids scores of pills otherwise required to achieve Linus Pauling's recommended high dosages.

WHEN TO START MAINTENANCE

Nobelist Linus Pauling and Matthias Rath, MD, identified a particle of LDL cholesterol called lipoprotein(s) or Lp(a) as the significant risk factor in heart and cardiovascular diseases. The original Cardio-C™ products contain proline, which anecdotally has a profound effect on lowering Lp(a). However, If Lp(a) is low, then Cardio-C XM is a good choice. Individuals differ, but some dosage level of vitamin C (and lysine) will maintain low Lp(a) cholesterol (e.g., < 3 mg/dl) and maintain total cholesterol at around 180 mg/dl. The exact maintenance dosage will differ among individuals, but these blood serum levels act as a guide.

Vitamin C Foundation founder Owen Fonorow says he wrote his book Practicing Medicine Without a License because heart patients following Pauling's regimen started to feel well, fast. Many of those who recovered often thought that they were "cured" and they stopped taking their vitamin C. Then they all started experiencing the same relapse: Almost invariably six months later, those who stopped their vitamin C would revert to their previous condition and suffer a heart attack or require stents.

Cardio-C™ XM has been designed to help long-time Pauling followers avoid this issue by giving them an economical long-term option.

Note: Those who aren't diagnosed with heart disease may find this formula useful as a daily preventive.

OFFER:

PURCHASE ONE RETAIL JAR OF CARDIO-C™ XM AT THE LOWER AUTOSHIP PRICE. USE COUPON CODE TRYXM AT OUR MAIN STORE AT CHECKOUT.

Cardio-C™ is a trademark of Inteligent*Vitamin*C Inc.

Owen Fonorow
Vitamin C Foundation
+1 800-894-9025
support@inteligentvitaminc.com
Visit us on social media:
Facebook
X
YouTube
Other

Linus Pauing's Recommended Dosages from the Unified Theory Lecture

Cardio-C XM Pauling Therapy Formula

[ofonorow]

Over the years, people have wondered if it is true, that Pauling/Rath discovered the reason for the number one killer and that Pauling invented a 100% cure, why doesn't every know about it?

The reason is that a wall of censorship exists. It was erected more than 30 years ago, and it doesn't take genius to figure out who is behind that wall.

Yes, there is an enormous amount of money involved, and these Press Release/Media companies have to consider their own balance sheets and bottom lines, but what happens when the population finds out? Finds out that the reason no one has been told that a 2 time Nobel prize winner invented a "100% cure for heart disease" (they don't even report that he made the claim) is because of Big Pharma greed and NIH malfeasance? These highly evil forces have deliberating kept information from the public that could have saved more than 400,000+ live per year, not to mention prevent 350,000 heart by-pass operations?

Me thinks that I would not want to be in their shoes.

So how to make these Press Release people feel the heat? That is the question. How to put 400,000 deaths on their back?

Thanks to Elon Musk, Twitter/X, I have been able to create a small hole in the Cone of Silence. Information about the Pauling invention is starting to leak out and people in general have become more sensitive to the idea that things are being kept from them that should not be kept from then in a truly free society. That the right to free speech is a basic right that others violate at their own peril.

[ofonorow]

EIN Presswire

6:49 AM (45 minutes ago)

to me
Hello Owen,

Thank you for reaching out.

Please note that we don't run content promoting Health Supplements:

See: https://www.einpresswire.com/editorial-guidelines

"Health Supplements: EIN Presswire does not allow any health supplement content, irrespective of any claims of legality."

If you have any questions, please reply to this email or use the contact
form at https://www.einpresswire.com/contact.

Best regards,

Editorial Department
EIN Presswire
Washington, DC

EIN Presswire - Everyone's Internet News Presswire™
https://www.einpresswire.com


On 2024-06-29 22:25:20 UTC, Owen Fonorow <owen.fonorow@gmail.com> wrote:
Sir,
You emailed me to submit a press release.

And our initial response

Ladies and Gentlemen,

Your requirement that the Press Release content not be a "health supplement" is absurd on its face.

Re: "Please note that we don't run content promoting Health Supplements:"

What kind of feedback would have made your company adopt such a restrictive policy?

There have been no recorded deaths due to a vitamin overdose, at least in the past 50 years.

According to the Journal of the American Medical Association, prescription and over-the-counter medications are the 3rd leading cause of death in the United States. Do you allow press releases for these products?

You'll note the PR was not "promoting" a health supplement, it was describing a new product that we hope to sell through big retail stores, e.g. Costco, Walmart/Sam's Club, and other retail chains.

Your decision note to publish our press release will have a direct negative impact on what is potentially a large source of business for us.

Again, I would like to contact your CEO. Please direct me.

Owen

[ofonorow]

Health Supplements: EIN Presswire does not allow any health supplement content, irrespective of any claims of legality.

Here is the excluded content we are combined with:

EIN Presswire does not distribute:

Advertisements: If your press release is primarily aimed at selling a product or service, then it is an advertisement and not a press release. A good press release informs the media and the general public about a newsworthy topic. If the primary purpose of the document is to sell without any other newsworthy element, then it will be denied publication.

False or Misleading Content: Content that is verifiably untrue or misleading.

Academic Writing Services: EIN Presswire does not publish releases that promote and/or link to academic writing services. This includes essay, dissertation, thesis, application, research, paper, assignment, and/or homework writing services.

Sexually Explicit Content: To ensure the integrity of our service for all, EIN Presswire does not accept content about sexually explicit material or products. Press releases should not contain references or links to explicitly sexual material, illegal material or profane language. Please note that all 18-and-older websites are considered sexually explicit.

Link SPAM: Please limit your link count to 1 per 100 words. This policy is in place to protect the value of the links in a press release and the value of links within the EIN Presswire network.

Reprints: News and feature images, articles, opinion columns, editorials or news stories from other websites or publications, especially if they are copyrighted, are not press releases.

Duplicate Content: A press release can only be distributed once through EIN Presswire. In addition, a significant majority of each press release must be original content. Templated content is not permitted. Using copyrighted content from other sources is a violation of EIN Presswire’s Terms of Service.

Third-Party Legal Releases: EIN Presswire only accepts press releases from law firms in which the firm is representing one of the parties in the case. EIN Presswire does not accept press releases regarding legal cases from third-party firms.

Potentially Malicious: EIN Presswire does not distribute content that in our opinion could harm or exact revenge upon an individual or group. This content is defined as anything that may: incite, advocate or express hatred, bigotry, racism or gratuitous violence; promote personal opinions attacking an individual or group; maliciously affect a company’s stock; or stalk, defame, defraud, degrade, shame or victimize an individual or group.

Adverse to our Ethos: EIN Presswire does not distribute content that is contrary to our beliefs in promoting an open and inclusive society. Please refer to the Company Ethos.

Written Authorization: In certain cases, such as with network marketing companies, with the use of a stock ticker symbol, or with major corporate announcements such as (but not limited to) those related to M&A, EIN Presswire may require written authorization from a company executive before a press release is approved for distribution. Independent representatives of network marketing companies, MLM or party plan companies must always obtain the express consent of the company’s executive.

Unauthorized Ticker Symbols: While we encourage our clients to use any ticker symbols they are authorized to use in their press releases, we will need to receive the proper authorization from the source company for each ticker symbol used.

Online Gambling: EIN Presswire does not publish releases that promote or link to online gambling, fantasy sports, and related sites that utilize a “pay-to-play” model for participation.

Payday or Short-Term Loans: EIN Presswire does not publish releases that promote or link to payday, short-term or other unsecured loan services.

Gun Topics: Press releases promoting the sale of handguns, rifles, shotguns, hunting guns, functioning antique guns, airsoft guns, paintball guns, bb guns, 3D-printed guns and any parts or component, whether finished or unfinished, that's essential to or enhances the functionality of a gun.

Online Pharmaceuticals: EIN Presswire does not accept releases from online pharmacies or websites that sell prescription drugs unless both the website and release explicitly state that a doctor’s prescription is required for purchase. In addition, pharmaceutical sites that are acceptable must be located within the United States or the United Kingdom.

Tobacco: Press releases promoting the sale of tobacco or any products containing tobacco, its consumption, or simulate tobacco smoking, e.g. vaping, e-cigarettes, herbal cigarettes.

Weight Loss Products: EIN Presswire does not allow any weight loss products or ingredients.

Health Supplements: EIN Presswire does not allow any health supplement content, irrespective of any claims of legality.

Sexual Enhancement Products: EIN Presswire does not allow press releases that promote sexual enhancement products.

Easy Money Schemes: EIN Presswire does not accept releases that promote make-money-online, work-from-home programs or get-rich-quick schemes.

Stock Recommendations: EIN Presswire does not accept releases that promote stock picks, trading bots, newsletters, alerts, recommendations, advice or reviews. Publicly traded companies may still promote their own news.

Forex Trading Platforms: EIN Presswire does not accept releases that promote the use of Forex trading platforms, Forex trading demo accounts, Leveraged or Funded Forex trading accounts, or AI-based Forex trading tools or bots. Organizations may submit releases that promote news about the Forex industry as a whole.

BlackHat SEO Tactics: EIN Presswire does not allow releases to promote or link to Black Hat SEO tactics and services. These types of services include, but are not limited to, keyword stuffing, link buying, and selling, link stuffing, over-hyphenated domains, paid social media followers, and reputation management.

Viruses, Scripts, and Codes: EIN Presswire does not accept releases that contain or link to any viruses, scripts, programs, web pages or any code that destroys, alters, or inhibits the operation of any computer systems.

Hello Owen,

Thank you for reaching out to us.

Because the product Cardio-C is a dietary supplement, this is considered a health supplement under our editorial guidelines and is therefore excluded. For reference, please see Section 3:
https://www.einpresswire.com/editorial-guidelines

The editorial decision to disapprove the press release is final. EIN Presswire reserves the right to disapprove and retract any release based on its sole discretion as outlined in the Terms of Service agreed to when creating the account, see: https://www.einpresswire.com/user-agreement

This decision is based on our editorial guidelines and an editorial review process. It has nothing to do with any single individual within our organization. Editorial guidelines are fairly applied to all our clients.


Best regards,

Client Services
EIN Presswire
Washington, DC

EIN Presswire - Everyone's Internet News Presswire™
https://www.einpresswire.com